Akamai holder plans sale of 6,200 shares

Akamai Technologies Inc. has a planned sale of up to 6,200 common shares of its stock on NASDAQ, with an aggregate market value of $785,974.00 and a date listed as 07/15/2026.

Accepted by SEC EDGAR 07/15/2026 - 04:02 PM EDT Learn about SEC filing dates

Rhea-AI Filing Summary

Akamai Technologies Inc. has a planned sale of up to 6,200 common shares of its stock on NASDAQ, with an aggregate market value of $785,974.00 and a date listed as 07/15/2026. The shares are held through Charles Schwab & Co., Inc. and relate to equity compensation awards, including Performance and Restricted Stock Lapses covering 3,053, 683 and 2,464 shares dated February 19, 2026, March 4, 2025 and February 21, 2025.

Key Figures

Shares planned for sale: 6,200 shares Aggregate market value: $785,974.00 CUSIP: 145385451 +4 more

7 metrics

Shares planned for sale 6,200 shares Planned sale of Akamai Technologies Inc. common stock

Aggregate market value $785,974.00 Value associated with 6,200 common shares to be sold

CUSIP 145385451 CUSIP listed for Akamai Technologies Inc. common stock

Planned sale date 07/15/2026 Date listed for proposed sale of the shares

Performance Stock Lapse block 3,053 shares Common stock related to Performance Stock Lapse dated 02/19/2026

Restricted Stock Lapse block 1 683 shares Common stock from Restricted Stock Lapse dated 03/04/2025

Restricted Stock Lapse block 2 2,464 shares Common stock from Restricted Stock Lapse dated 02/21/2025

Key Terms

Performance Stock Lapse, Restricted Stock Lapse, Equity Compensation, Securities To Be Sold

4 terms

Performance Stock Lapse financial

"Common | 02/19/2026 | Performance Stock Lapse | AKAMAI TECHNOLOGIES INC"

Restricted Stock Lapse financial

"Common | 03/04/2025 | Restricted Stock Lapse | AKAMAI TECHNOLOGIES INC"

Equity Compensation financial

"3053 | 02/19/2026 | Equity Compensation Common | 03/04/2025"

Equity compensation is pay given to employees, executives or contractors in the form of company ownership—such as stock, stock options or restricted shares—rather than just cash. It matters to investors because it can align workers' incentives with shareholders (like paying someone in slices of the same pie they help grow), but it also increases the number of shares outstanding and company expenses, affecting ownership percentages and earnings per share.

Securities To Be Sold regulatory

"144: Securities To Be Sold Common | 02/19/2026 | Performance"

FAQ

AI-generated questions and answers. How Rhea-AI works. Not financial advice.

What stock sale is planned for Akamai Technologies (AKAM)?

A planned sale covers up to 6,200 common shares of Akamai Technologies Inc. stock. These shares are associated with equity compensation awards and are listed for trading on NASDAQ, providing liquidity for the holder while using standard brokerage channels.

What is the total value of Akamai (AKAM) shares planned for sale?

The planned sale has an aggregate market value of $785,974.00 for 6,200 common shares. This value reflects the market-based calculation associated with the notice and indicates the approximate dollar size of the proposed transaction in Akamai stock.

When is the Akamai Technologies (AKAM) share sale scheduled?

The proposed sale is listed with a date of 07/15/2026. This date reflects when the holder expects to be able to execute sales of the 6,200 common shares, subject to market conditions and any applicable trading restrictions.

Which broker and exchange are involved in the Akamai (AKAM) stock sale?

The shares are held through Charles Schwab & Co., Inc. and are planned to be sold on the NASDAQ market. This combination indicates the execution venue and intermediary that will handle the proposed sale of Akamai common stock.

What is the source of the Akamai (AKAM) shares being sold?

The shares come from equity compensation, including a Performance Stock Lapse of 3,053 shares dated February 19, 2026 and Restricted Stock Lapses of 683 and 2,464 shares dated March 4, 2025 and February 21, 2025, respectively.

AI-generated analysis. How Rhea-AI works. Not financial advice.

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

Form 144 Filer Information	UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 144 NOTICE OF PROPOSED SALE OF SECURITIES PURSUANT TO RULE 144 UNDER THE SECURITIES ACT OF 1933
FORM 144

144: Filer Information

Filer CIK	0001845574
Filer CCC	XXXXXXXX
Is this a LIVE or TEST Filing?	LIVE TEST
Submission Contact Information
Name
Phone
E-Mail Address

144: Issuer Information

Name of Issuer	AKAMAI TECHNOLOGIES INC
SEC File Number	000-27275
Address of Issuer	145 BROADWAY CAMBRIDGE MASSACHUSETTS 02142
Phone	6174443000
Name of Person for Whose Account the Securities are To Be Sold	Joseph Paul C
See the definition of "person" in paragraph (a) of Rule 144. Information is to be given not only as to the person for whose account the securities are to be sold but also as to all other persons included in that definition. In addition, information shall be given as to sales by all persons whose sales are required by paragraph (e) of Rule 144 to be aggregated with sales for the account of the person filing this notice.
Relationship to Issuer	Officer

144: Securities Information

Title of the Class of Securities To Be Sold	Name and Address of the Broker	Number of Shares or Other Units To Be Sold	Aggregate Market Value	Number of Shares or Other Units Outstanding	Approximate Date of Sale	Name the Securities Exchange
Common	Charles Schwab & Co., Inc. 3000 Schwab Way Westlake TX 76262	6200	785974.00	145385451	07/15/2026	NASDAQ

Furnish the following information with respect to the acquisition of the securities to be sold and with respect to the payment of all or any part of the purchase price or other consideration therefor:

144: Securities To Be Sold

Title of the Class	Date you Acquired	Nature of Acquisition Transaction	Name of Person from Whom Acquired	Is this a Gift?	Date Donor Acquired	Amount of Securities Acquired	Date of Payment	Nature of Payment *
Common	02/19/2026	Performance Stock Lapse	AKAMAI TECHNOLOGIES INC			3053	02/19/2026	Equity Compensation
Common	03/04/2025	Restricted Stock Lapse	AKAMAI TECHNOLOGIES INC			683	03/04/2025	Equity Compensation
Common	02/21/2025	Restricted Stock Lapse	AKAMAI TECHNOLOGIES INC			2464	02/21/2025	Equity Compensation

* If the securities were purchased and full payment therefor was not made in cash at the time of purchase, explain in the table or in a note thereto the nature of the consideration given. If the consideration consisted of any note or other obligation, or if payment was made in installments describe the arrangement and state when the note or other obligation was discharged in full or the last installment paid.

Furnish the following information as to all securities of the issuer sold during the past 3 months by the person for whose account the securities are to be sold.

144: Securities Sold During The Past 3 Months

Nothing to Report

144: Remarks and Signature

Remarks	The shares sold in this filing may be sold over various dates.
Date of Notice	07/15/2026
Date of Plan Adoption or Giving of Instruction, If Relying on Rule 10b5-1	03/04/2026
ATTENTION:
The person for whose account the securities to which this notice relates are to be sold hereby represents by signing this notice that he does not know any material adverse information in regard to the current and prospective operations of the Issuer of the securities to be sold which has not been publicly disclosed. If such person has adopted a written trading plan or given trading instructions to satisfy Rule 10b5-1 under the Exchange Act, by signing the form and indicating the date that the plan was adopted or the instruction given, that person makes such representation as of the plan adoption or instruction date.
Signature	PAUL C JOSEPH
ATTENTION: Intentional misstatements or omission of facts constitute Federal Criminal Violations (See 18 U.S.C. 1001)